Tables--Technology Assessment: Genetic Tests for Cancer. Database III

You Are Here: AHRQ Home > Clinical Information > Technology Assessments > Genetic Tests for Cancer

Database III: Genetic tests in development

Database of genetic tests in development

Table III-1: Test (by major types of cancer)

Name	Other Name	Use	Breast	Prostate	Lung	Colorectal	Ovarian	Liver	Leukemia	Other
AFP-L3		Primary prevention						x
Alpha Catenin	Methylation marker	Prognosis	x
APC		Detection				x
BAT-26	Microsatallite instability	Detection				x
Bladder cancer test		Diagnosis								x
BladderChek	NMP22	Diagnosis								x
Breast Cancer Detection	Nipple Aspirate Fluid	Diagnosis	x
Breast Cancer Outcome Prediction Test	PIX2/TTF1	Diagnosis	x
Cancer antigen 72-4	CA 72-4	Diagnosis								x
CDK family	Cyclin dependent kinase family	Management			x
CDKN24	Methylation marker	Detection				x
CDP/Cux		Diagnosis	x
CellSearch	Circulating tumor cells	Diagnosis	x
CeMines CellCorrect Lab		Diagnosis			x
Chromosome 8q gain		Management					x
c-Kit pharmDx	Gleevec sensitivity test	Management								x
Colorectal cancer test		Diagnosis				x
Colorectal gene panel	7 gene pharmacogenomic panel	Management				x
Colorectalert		Diagnosis				x
Conversion Analysis	Conversion Technology	Diagnosis				x
Cox-2 RNA	Stool	Detection				x
cPSA	Complexed PSA	Management		x
CupPrint		Management								x
Cyfra 21-1	Cytokeratin fragment 19	Diagnosis			x
Cytokeratin 20	CK 20	Diagnosis				x
CytoVision		Diagnosis							x
des-gamma carboxyprothrombin		Detection						x
DNA methylation	Oncomethylome	Detection		x	x		x			x
DNA methylation	Second Code	Diagnosis		x	x	x
EEF1A2	Elongation factor	Management	x
EGFR	Genzyme	Detection			x		x			x
EGFR		Management			x
EPCA		Diagnosis		x
eTag		Management	x		x
Genomic Test	3q, 7q, 16q, 17pter-q21	Diagnosis					x
GOS	Stool	Detection				x
GSTM1		Prediction			x
GSTP1		Management		x
Her-1, Her-2, Her-3, Her-4		Diagnosis	x
HLA-E		Prognosis								x
HP1alpha		Management	x
HPV test	DNA with Pap Test	Diagnosis								x
HPV test	Human papilloma virus cell swab	Diagnosis								x
IGF-II		Prediction								x
IMI breast cancer test		Diagnosis	x
Immunocyt/ uCyt		Diagnosis								x
Iressa test		Management			x
Key2		Diagnosis	x
K-ras		Detection			x	x
Leukemia Affymetrix Chip		Diagnosis							x
Leukemia blood test	MRD test	Recurrence							x
Lung cancer test		Diagnosis			x
Lung cancer test	Electronic Nose	Diagnosis			x
LungAlert		Diagnosis			x
Lysophopholipids	LPA	Detection					x
M2-PK		Primary prevention				x
MammaPrint		Management	x
Matrix metalloproeinases	MMP	Detection					x
Melanoma inhibiting antigen	MIA	Diagnosis								x
Melastatin	mRNA expression	Management								x
MESOMARK		Diagnosis								x
MGMT	Methylation marker	Detection				x
Microsatelitte Analysis	Urine MicroSatellite Analysis	Detection								x
MLH1	Methylation marker	Detection				x
MN protein		Detection					x
MSA		Management								x
MSA analysis	Microsatellite DNA	Diagnosis								x
NAF test		Diagnosis	x
NMP179		Diagnosis								x
NMP22	Matritek's Bladderchek test	Detection								x
NMP35		Diagnosis				x
NMP48		Diagnosis		x
NMP66		Diagnosis	x
OncoVue breast cancer risk test	Tagit	Primary prevention	x
Ovacheck		Diagnosis					x
Ovarian cancer biomarker test		Diagnosis					x
Ovarian cancer test		Diagnosis					x
Ovarian cancer test	Ovarian Cancer Prognostic Profile	Management					x
Ovarian pap test		Detection					x
p16, p15, p14 deletions		Management							x	x
p202		Management		x
p53 Affymetrix Chip		Diagnosis	x
Prostate 63	AsymmetRx	Management		x
Prostate biomarkers		Management		x
Prostate Cancer Blood Test	ProteomeDx	Diagnosis		x
Protein Profile test	Lysophosphatidic acid (LPA)	Recurrence					x
PSA testing	In office	Diagnosis		x
PSMA	Prostate specific membrane antigen	Management		x
PSP94	Prostate secratory protein	Diagnosis		x
PTEN tumor suppressor		Management		x
PyloriProbe	DR70	Diagnosis				x
Recaf	Alpha feto protein receptor	Diagnosis	x	x	x	x
RhoC GTPase		Management	x
S100		Diagnosis								x
SELDI-TOF-MS	Molecular profiling using SELDI	Management	x	x	x		x
SurePath		Diagnosis								x
Telomerase	hTR, HTerRT	Diagnosis								x
TGF genes		Prognosis	x
TUO test		Diagnosis								x
uPM3	PCA3 assay	Diagnosis		x
Urinary plasminogen activator	suPAR	Detection					x
Urine test for cervical cancer		Diagnosis								x
VEGF		Management				x
WISP3		Management	x

Return to Contents
Proceed to Next Section